All In Biotech

Drug Trial Radar · NCT02686138

A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C

A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)

Last checked: Nov 19, 2026Latest source record: Apr 22, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 593 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

593

Actual

Start

Dec 2015

Primary completion

Aug 2017

Study completion Oct 2017

Sponsor

Lead sponsor
ArdelyxIndustry
Sponsor type
Industry
First posted
Feb 19, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This phase 3, 26-week, randomized, double-blind, placebo-controlled, multi-center study will evaluate the safety and efficacy of one dose of Tenapanor in subjects with constipation-predominant irritable bowel syndrome (IBS-C) as defined by the ROME III criteria and who have active disease as determined after a two-week screening period. Subjects who qualify and are randomized into the study will either receive 50mg BID of Tenapanor (1:1) for a 26 week treatment period.

Conditions

  • Constipation Predominant Irritable Bowel Syndrome

Interventions

  • TenapanorDrug

  • PlaceboDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Subjects With Overall Response for 6 Out of 12 WeeksTime frame: First 12 weeks

Locations

117 sites in 1 country. Site status is shown where the registry gives one.

  • Ardelyx Investigative Site 257

    Dothan, Alabama

  • Ardelyx Investigative Site 200

    Foley, Alabama

  • Ardelyx Investigative Site 103

    Huntsville, Alabama

  • Ardelyx Investigative Site 244

    Huntsville, Alabama

  • Ardelyx Investigative Site 251

    Huntsville, Alabama

  • Ardelyx Investigative Site 100

    Huntsville, Alabama

  • Ardelyx Investigative Site 209

    Saraland, Alabama

  • Ardelyx Investigative Site 210

    Phoenix, Arizona

  • Ardelyx Investigative Site 296

    Phoenix, Arizona

  • Ardelyx Investigative Site 269

    Tucson, Arizona

  • Ardelyx Investigative Site 256

    Tucson, Arizona

  • Ardelyx Investigative Site 292

    Conway, Arkansas

  • Ardelyx Investigative Site 122

    Little Rock, Arkansas

  • Ardelyx Investigative Site 163

    Anaheim, California

  • Ardelyx Investigative Site 105

    Canoga Park, California

  • Ardelyx Investigative Site 143

    Chula Vista, California

  • Ardelyx Investigative Site 147

    Encino, California

  • Ardelyx Investigative Site 297

    La Mesa, California

  • Ardelyx Investigative Site 284

    La Mirada, California

  • Ardelyx Investigative Site 107

    Lomita, California

  • Ardelyx Investigative Site 165

    Long Beach, California

  • Ardelyx Investigative Site 211

    Orange, California

  • Ardelyx Investigative Site 233

    Wheat Ridge, Colorado

  • Ardelyx Investigative Site 212

    Bristol, Connecticut

  • Ardelyx Investigative Site 176

    Brandon, Florida

  • Ardelyx Investigative Site 178

    Cutler Bay, Florida

  • Ardelyx Investigative Site 136

    Hialeah, Florida

  • Ardelyx Investigative Site 130

    Hialeah, Florida

  • Ardelyx Investigative Site 191

    Lynn Haven, Florida

  • Ardelyx Investigative Site 288

    Miami, Florida

  • Ardelyx Investigative Site 106

    Miami, Florida

  • Ardelyx Investigative Site 127

    Miami Lakes, Florida

  • Ardelyx Investigative Site 179

    Orlando, Florida

  • Ardelyx Investigative Site 290

    Tampa, Florida

  • Ardelyx Investigative Site 254

    West Palm Beach, Florida

  • Ardelyx Investigative Site 138

    Atlanta, Georgia

  • Ardelyx Investigative Site 148

    Atlanta, Georgia

  • Ardelyx Investigative Site 253

    Atlanta, Georgia

  • Ardelyx Investigative Site 272

    Decatur, Georgia

  • Ardelyx Investigative Site 229

    Decatur, Georgia

Showing 40 of 117 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.